ENLV

Enlivex Ltd. is a clinical-stage immunotherapy company developing Allocetra, an off-the-shelf cell therapy that reprograms macrophages to treat inflammatory conditions, with osteoarthritis as the primary focus. Beyond its clinical pipeline, Enlivex operates a treasury strategy centered on the RAIN token, a digital asset linked to decentralized prediction markets infrastructure. The company is in early-stage development for its therapeutic program while simultaneously building a treasury reserve model around cryptocurrency holdings.

Pipeline

Catalyst Calendar